Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

First Page		Document Content
Date: 2016-08-04 23:27:20 Breakthrough therapy Chemistry Pharmaceutical sciences Carbamates Pharmacology Pyrrolidines Ombitasvir/paritaprevir/ritonavir Ritonavir Ombitasvir AbbVie Inc. Paritaprevir Kidney		Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio Add to Reading List Source URL: www.pmda.go.jp Download Document from Source Website File Size: 95,95 KB Share Document on Facebook

	Breakthrough Cancer Therapy DTC DocID: 1sYyU - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qWZQ - View Document
	24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box DocID: 1qVSm - View Document
	12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O DocID: 1qRuM - View Document